Sign in
4

Changes in Ownership

Protagenic Therapeutics, Inc.new Filed Acc 0001170918-07-000170

Options or other derivatives

  • Chief Executive Officer acquired 24,375,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Katz Burton Chief Executive Officer 2007-02-16 Grant or award · Options to Purchase Common Stock +24,375,000 24,375,000 D
Loading xslF345X02/sam07-060_ex.xml…